Abiopharma

McLain William Thomas Jr. 🟢 acquired 3.7K shares of EASTMAN CHEMICAL CO (EMN) at $68.73 Transaction Date: Aug 27, 2025 | Filing ID: 000003

New Form 8-K - Keros Therapeutics, Inc. Filed: 2025-08-28 AccNo: 0001664710-25-000078 Size: 213 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Nurix Therapeutics to Participate in Upcoming Investor Conferences

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

Director Costa Mark J 🟢 acquired 7.4K shares of EASTMAN CHEMICAL CO (EMN) at $67.89 Transaction Date: Aug 27, 2025 | Filing ID: 000004

New Form S-8 - VivoSim Labs, INC. Filed: 2025-08-28 AccNo: 0001193125-25-191220 Size: 220 KB

New Form DEFA14A - Phio Pharmaceuticals Corp. Filed: 2025-08-28 AccNo: 0001683168-25-006511 Size: 16 KB

Ascendis Pharma to Participate in the 2025 Wells Fargo Healthcare Conference

Kezar Life Sciences to Participate in Two Upcoming Investor Conferences

Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate

Align Technology to Speak at Upcoming Financial Conferences

Notification from CorMedix Inc.

The Latest on Halo: Updates, Future Plans, and What’s Next

Employee Spotlight: Kyle McBard